2002
DOI: 10.1038/sj.onc.1205210
|View full text |Cite
|
Sign up to set email alerts
|

SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptor

Abstract: We have previously shown that the binding site for GTPase activating protein of Ras (RasGAP) in the PDGF b-receptor, Tyr771, is phosphorylated to a much lower extent in the heterodimeric con®guration of PDGF a-and b-receptors, compared to the PDGF b-receptor homodimer. The decreased recruitment of the RasGAP to the receptor leads to prolonged activation of the Ras/ MAP kinase pathway, which could explain the increase in mitogenicity seen upon induction of heterodimers. The molecular mechanism underlying these … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
31
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(34 citation statements)
references
References 33 publications
3
31
0
Order By: Relevance
“…However, studies that have been done so far on PDGF receptor dephosphorylation support the notion that selectivity in dephosphorylation is a common feature. Deletion of the binding site for SHP-2 results in a specific increase in the phosphorylation of Y771 in PDGF ␣ and ␤ receptor heterodimeric complexes (9). Also, DEP-1 dephosphorylation of the PDGF ␤ receptor displays site selectivity, with Y1021 and Y857 occurring as preferred and nonpreferred sites, respectively (22,32).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, studies that have been done so far on PDGF receptor dephosphorylation support the notion that selectivity in dephosphorylation is a common feature. Deletion of the binding site for SHP-2 results in a specific increase in the phosphorylation of Y771 in PDGF ␣ and ␤ receptor heterodimeric complexes (9). Also, DEP-1 dephosphorylation of the PDGF ␤ receptor displays site selectivity, with Y1021 and Y857 occurring as preferred and nonpreferred sites, respectively (22,32).…”
Section: Discussionmentioning
confidence: 99%
“…The peptides were conjugated to keyhole limpet hemocyanin by using m-maleimido benzoyl-N-hydroxysuccinimide ester (Pierce), and the conjugates were used to immunize rabbits. The antibodies were affinity purified by passing the antiserum over three consecutive columns of immobilized nonphosphorylated peptide, phosphotyrosine-agarose, and phosphorylated peptide as previously described (9). The peptides were coupled to Sulfolink (Pierce) and phosphotyrosine was coupled to Affigel 10 (Bio-Rad) according to the manufacturers' instructions.…”
Section: Methodsmentioning
confidence: 99%
“…First, our results indicate a greater PDGF-dependent increase in Shp-2 phosphorylation compared with other targets in the cells expressing tTG. Furthermore, Shp-2 regulates PDGFR signaling by acting as a sensor of cell-matrix interactions (2,23,24), and cell surface tTG enhances cell-ECM adhesion. Finally, forced Shp-2 targeting to lipid rafts, the membrane domains in which tTG is present (25,26) and integrins and PDGFR accumulate, promotes cell adhesion, and spreading and activates focal adhesion kinase and RhoA (27), all reported features of tTG overexpression phenotype (13).…”
Section: Discussionmentioning
confidence: 99%
“…For example, expression of spry genes in Drosophila and mouse embryos is largely confined to FGF signaling centers (Hacohen et al, 1998;Minowada et al, 1999). In RTK signaling processes where Spry proteins are not expressed, Csw/SHP-2 must stimulate signaling by dephosphorylating other substrates, such as the autophosphorylation site on EGFR and Torso/PDGFRs that recruits RasGAP (Cleghon et al, 1998;Ekman et al, 2002;Agazie and Hayman, 2003b) or sites on Src kinase regulators (Ren et al, 2004;Zhang et al, 2004). In some pathways, such as the Torso pathway, more than one Csw/SHP-2 substrate is likely to be present and regulated by the enzyme (Cleghon et al, 1998;Casci et al, 1999).…”
Section: G547ementioning
confidence: 99%
“…One is the phosphotyrosines on Torso, PDGFR and EGFR that mediate binding and signal inhibition by RasGAP (Cleghon et al, 1998;Ekman et al, 2002;Agazie and Hayman, 2003b). The other is the CSKbinding proteins Paxillin and PAG/Cbp, dephosphorylation of which prevent CSK-mediated inactivation of Src kinase activity and its positive effect on RTK signaling (Ren et al, 2004;Zhang et al, 2004).…”
Section: Introductionmentioning
confidence: 99%